Kevin Patrick Moran, SVP, CFO & Treasurer at Vanda Pharmaceuticals Inc. (VNDA), sold 21,137 shares at $11.28 ($238K) on 2022-03-02, disclosed to the SEC on 2022-03-02.
Open-market sale of $238k VNDA by SVP, CFO & Treasurer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.19 | 3,473 | $39K | 16.3% |
| 2 | $11.28 | 8,832 | $100K | 41.8% |
| 3 | $11.28 | 8,832 | $100K | 41.8% |
| Total | $11.27 avg | 21,137 | $238K | 100% |
| Filing → |
| VNDA | SELL | 2024-07-29 | $13K | — | Filing → |
| VNDA | SELL | 2024-03-06 | $63K | — | Filing → |
| VNDA | SELL | 2023-08-01 | $14K | — | Filing → |